Contineum Therapeutics, Inc.
(CTNM - NASDAQ)
16,70 USD
📋 Profilo Aziendale

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States.

|